TEL AVIV Israel's fast-moving vaccination program, which has already reached a third of the population, is built on a bargain. The vaccine maker agreed to keep up the quick-time delivery of doses in exchange for partial access to the vast database of information maintained by the country's national health-care system.
Already, researchers here and in other countries are getting their first look at how the crash-effort vaccine performs at population level. The Israeli results show cause for hope, including preliminary findings that infection rates plummeted to near zero in 128,000 people who got two rounds of vaccine. Other findings, though, revealed less immunity than expected after just one dose, leading health officials in some countries to retool their rollout efforts.
But some privacy advocates are complaining that Israelis are being used as guinea pigs without their permission after learning that Pfizer, maker of the vaccine that Israel has injected into the arms of about one third of its 9 million people, got access to health data as a condition of the deal.
https://www.washingtonpost.com/world/middle_east/israel-pfizer-coronavirus-vaccine-privacy/2021/01/27/b9773c80-5f4d-11eb-a177-7765f29a9524_story.html